Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway

Molecular Nutrition and Food Research

Volumn 57, Issue 9, 2013, Pages 1649-1659

  Soetikno, Vivian ^a,b   Sari, Flori R ^a   Lakshmanan, Arun P ^a   Arumugam, Somasundaram ^a   Harima, Meilei ^a   Suzuki, Kenji ^c   Kawachi, Hiroshi ^c   Watanabe, Kenichi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b UNIVERSITY OF INDONESIA   (Indonesia)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Chronic kidney disease; Curcumin; Fibrosis; Inflammation; Oxidative stress

Indexed keywords

ANIMALIA; RATTUS;

BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; CREATININE; CURCUMIN; CYCLOOXYGENASE 2; FIBRONECTIN; HEME OXYGENASE; HMOX1 PROTEIN, RAT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KEAP1 PROTEIN, RAT; NFE2L2 PROTEIN, RAT; PTGS2 PROTEIN, RAT; SIGNAL PEPTIDE; TELMISARTAN; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; DRUG EFFECT; FIBROSIS; GENETICS; INFLAMMATION; KIDNEY; KIDNEY DISEASE; MALE; METABOLISM; NEPHRECTOMY; OXIDATIVE STRESS; PATHOLOGY; PROTEINURIA; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; UREA NITROGEN BLOOD LEVEL;

CHRONIC KIDNEY DISEASE; CURCUMIN; FIBROSIS; INFLAMMATION; OXIDATIVE STRESS;

ANIMALS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; BLOOD UREA NITROGEN; CREATININE; CURCUMIN; CYCLOOXYGENASE 2; FIBRONECTINS; FIBROSIS; HEME OXYGENASE (DECYCLIZING); INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY DISEASES; MALE; NEPHRECTOMY; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATIVE STRESS; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883454341     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200540     Document Type: Article

References (44)

1. Fujimoto, S., Satoh, M., Horike, H., Hatta, H. et al., Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production. Hypertens. Res. 2008, 31, 305-313.
2. Modlinger, P. S., Wilcox, C. S., Aslam, S., Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin. Nephrol. 2004, 24, 354-365.
3. Rodríguez-Iturbe, B., Pons, H., Herrera-Acosta, J., Johnson, R. J., Role of immunocompetent cells in nonimmune renal diseases. Kidney Int. 2001, 59, 1626-1640.
4. Gill, P. S., Wilcox, C. S., NADPH oxidases in the kidney. Antioxid. Redox. Signal. 2006, 8, 1597-1607.
5. Li, W., Khor, T. O., Xu, C., Shen, G. et al., Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem. Pharmacol. 2008, 76, 1485-1489.
6. Surh, Y. J., Kundu, J. K., Na, H. K., Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med. 2008, 74, 1526-1539.
7. Chen, X. L., Kunsch, C., Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr. Pharm. Des. 2004, 10, 879-891.
8. Surh, Y. J., Chun, K. S., Cancer chemopreventive effects of curcumin. Adv. Exp. Med. Biol. 2007, 595, 149-172.
9. Balogun, E., Hoque, M., Gong, P., Killeen, E. et al., Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem. J. 2003, 371, 887-895.
10. He, H. J., Wang, G. Y., Gao, Y., Ling, W. H. et al., Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. World J. Diabetes 2012, 3, 94-104.
11. Ghosh, S. S., Massey, H. D., Krieg, R., Fazelbhoy, Z. A. et al., Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation. Am. J. Physiol. Renal Physiol. 2009, 296, F1146-F1157.
12. Tsunenari, I., Ohmura, T., Seidler, R., Chachin, M. et al., Renoprotective effects of telmisartan in the 5/6 nephrectomised rats. J. Renin Angiotensin Aldosterone Syst. 2007, 8, 93-100.
13. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
14. Rapoport, A., Husdan, H., Endogenous creatinine clearance and serum creatinine in the clinical assessment of kidney function. Can. Med. Assoc. J. 1968, 99, 149-156.
15. Foster, L. B., Hochholzer, J. M., A single-reagent manual method for directly determining urea nitrogen in serum. Clin. Chem. 1971, 17, 921-925.
16. Kim, H. J., Vaziri, N. D., Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am. J. Physiol. Renal Physiol. 2010, 298, F662-F671.
17. An, W. S., Kim, H. J., Cho, K. H., Vaziri, N. D., Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am. J. Physiol. Renal Physiol. 2009, 297, F895-F903.
18. Ram, C. V., Angiotensin receptor blockers: current status and future prospects. Am. J. Med. 2008, 121, 656-663.
19. Lee, Y. J., Cho, S., Kim, S. R., Jang, H. R. et al., Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease. Postgrad. Med. J. 2011, 87, 664-669.
20. Vaziri, N. D., Bai, Y., Ni, Z., Quiroz, Y. et al., Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J. Pharmacol. Exp. Ther. 2007, 323, 85-93.
21. Kim, H. J., Sato, T., Rodríguez-Iturbe, B., Vaziri, N. D., Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis. J. Pharmacol. Exp. Ther. 2011, 337, 583-590.
22. Aminzadeh, M. A., Sato, T., Vaziri, N. D., Participation of endoplasmic reticulum stress in the pathogenesis of spontaneous glomerulosclerosis-Role of intra-renal angiotensin system. Transl. Res. 2012, 160, 309-318.
23. Fujita, H., Fujishima, H., Morii, T., Sakamoto, T. et al., Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice. Hypertens. Res. 2012, 35, 213-220.
24. Toba, H., Tojo, C., Wang, J., Noda, K. et al., Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat. Eur. J. Pharmacol. 2012, 685, 91-98.
25. Small, D. M., Coombes, J. S., Bennett, N., Johnson, D. W. et al., Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton) 2012, 17, 311-321.
26. Li, W., Kong, A. N., Molecular mechanisms of Nrf2-mediated antioxidant response. Mol. Carcinog. 2009, 48, 91-104.
27. Chan, J. Y., Kwong, M., Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim. Biophys. Acta 2000, 1517, 19-26.
28. Yoh, K., Hirayama, A., Ishizaki, K., Yamada, A. et al., Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice. Genes Cells 2008, 13, 1159-1170.
29. Yoh, K., Itoh, K., Enomoto, A., Hirayama, A. et al., Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int. 2001, 60, 1343-1353.
30. Zhou, H., Beevers, C. S., Huang, S., The targets of curcumin. Curr. Drug Targets 2011, 12, 332-347.
31. Jeong, S. O., Oh, G. S., Ha, H. Y., Soon Koo, B. et al., Dimethoxycurcumin, a Synthetic Curcumin Analogue, induces heme oxygenase-1 expression through Nrf2 activation in RAW264.7 macrophages. J. Clin. Biochem. Nutr. 2009, 44, 79-84.
32. Donadelli, R., Zanchi, C., Morigi, M., Buelli, S. et al., Protein overload induces fractalkine upregulation in proximal tubular cells through nuclear factor kappaB- and p38 mitogen-activated protein kinase-dependent pathways. J. Am. Soc. Nephrol. 2003, 14, 2436-2446.
33. Ha, H., Yu, M. R., Choi, Y. J., Kitamura, M. et al., Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J. Am. Soc. Nephrol. 2002, 13, 894-902.
34. Gong, R., Rifai, A., Tolbert, E. M., Biswas, P. et al., Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES. J. Am. Soc. Nephrol. 2004, 15, 2868-2881.
35. Donadelli, R., Abbate, M., Zanchi, C., Corna, D. et al., Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation. Am. J. Kidney Dis. 2000, 36, 1226-1241.
36. Khor, T. O., Huang, M. T., Kwon, K. H., Chan, J. Y. et al., Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res. 2006, 66, 11580-11584.
37. Jeong, W. S., Kim, I. W., Hu, R., Kong, A. N., Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm. Res. 2004, 21, 661-670.
38. Braun, S., Hanselmann, C., Gassmann, M. G., auf dem Keller, U. et al., Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol. Cell Biol. 2002, 22, 5492-5505.
39. Rangasamy, T., Cho, C. Y., Thimmulappa, R. K., Zhen, L. et al., Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 2004, 114, 1248-1259.
40. Kim, H. J., Moradi, H., Yuan, J., Norris, K. et al., Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am. J. Physiol. Renal Physiol. 2009, 296, F1297-F1306.
41. Border, W. A., Noble, N. A., Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 1994, 331, 1286-1292.
42. Inoue, T., Okada, H., Kobayashi, T., Watanabe, Y. et al., Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J. 2003, 17, 268-270.
43. Deelman, L., Sharma, K., Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Curr. Opin. Nephrol. Hypertens. 2009, 18, 85-90.
44. Bakin, A. V., Stourman, N. V., Sekhar, K. R., Rinehart, C. et al., Smad3-ATF3 signaling mediates TGF-beta suppression of genes encoding phase II detoxifying proteins. Free Radic. Biol. Med. 2005, 38, 375-387.